Legal Representation
Attorney
Casimir W. Cook II
USPTO Deadlines
Next Deadline
1882 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-09-10)
Due Date
September 10, 2030
Grace Period Ends
March 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 10, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 10, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 25, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 25, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 5, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 20, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 11, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 11, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 11, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 5, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 5, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 5, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 5, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 13, 2023 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jun 11, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 15, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Software as a service (SAAS) services featuring software for enabling users to collect documents, capture data, manage workflows, analyze data, comply with laws and regulations, and maintain an audit trail around investigational medicines and medicine clinical trial processes requiring collaboration between life sciences companies, health care providers, and patients; Software as a service (SAAS) services featuring software for use by life sciences companies, health care providers, and patients to collaborate about access to investigational medicines for treatment and research in the areas of expanded access and compassionate use of investigational medicines, investigator-initiated investigational medicine studies, post-clinical trial access to investigational medicines, and participation in clinical trials; Software as a service (SAAS) services, namely, hosting software for use by others for managing and processing requests for access to investigational medicines in the areas of expanded access and compassionate use of investigational medicines, investigator-initiated investigational medicine studies, post-clinical trial access to investigational medicines, and participation in clinical trials
First Use Anywhere:
Apr 3, 2021
First Use in Commerce:
Apr 3, 2021
Additional Information
Design Mark
The mark consists of four geometric shapes oriented to form a cross with the outline of the letter "M" in the middle.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
MEDASYSTEMS
Classification
International Classes
042